Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Incretin System on Brain Insulin Sensitivity in Humans with Normal Weight, Overweight and Obesity

NCT06487832 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT06487832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06487832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Incretin System on Brain Insulin Sensitivity in Humans with Normal Weight, Overweight and Obesity
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2024
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, insulin sensitivity, normal weight, overweight and obesity